Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02).
- DOI
- 10.3324/haematol.2024.286807
- Published
- 2025 Oct 1
- Container
- Haematologica
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3324/haematol.2024.286807,
title = {Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02).},
author = {Bertoli S and Bérard E and Peterlin P and Guieze R and Desbrosses Y and Hicheri Y and Benbrahim O and Carre M and Orvain C and Banos A and Bernard M and Gyan E and Saad A and Chebrek S and Guepin GR and Dorvaux V and Sanhes L and Gallego-Hernanz MP and Exbrayat C and Vincent L and Himberlin C and Simand C and Vey N and Fenoll C and Mineur A and Huynh A and Vergez F and Luquet I and Largeaud L and Delabesse E and Pigneux A and Récher C},
year = {2025},
journal = {Haematologica},
doi = {10.3324/haematol.2024.286807},
url = {https://doi.org/10.3324/haematol.2024.286807}
}RIS
TY - JOUR TI - Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02). AU - Bertoli S AU - Bérard E AU - Peterlin P AU - Guieze R AU - Desbrosses Y AU - Hicheri Y AU - Benbrahim O AU - Carre M AU - Orvain C AU - Banos A AU - Bernard M AU - Gyan E AU - Saad A AU - Chebrek S AU - Guepin GR AU - Dorvaux V AU - Sanhes L AU - Gallego-Hernanz MP AU - Exbrayat C AU - Vincent L AU - Himberlin C AU - Simand C AU - Vey N AU - Fenoll C AU - Mineur A AU - Huynh A AU - Vergez F AU - Luquet I AU - Largeaud L AU - Delabesse E AU - Pigneux A AU - Récher C PY - 2025 JO - Haematologica DO - 10.3324/haematol.2024.286807 UR - https://doi.org/10.3324/haematol.2024.286807 ER -
APA
S, B., E, B., P, P., R, G., Y, D., Y, H., O, B., M, C., C, O., A, B., M, B., E, G., A, S., S, C., GR, G., V, D., L, S., MP, G., C, E., L, V., C, H., C, S., N, V., C, F., A, M., A, H., F, V., I, L., L, L., E, D., A, P., & C, R. (2025). Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02).. Haematologica. https://doi.org/10.3324/haematol.2024.286807
Source records
- pubmed · retrieved 2026-09-27T10:31:25.994Z